SLC12A5 and glioblastoma: The differences between the PBT24 and SF8628 control tumors in the PCNA, EZH2, and EZH2–p53 correlation expression in the tumor on the CAM, and the SLC12A5 expression in the studied cells suggested a possible distinct malignancy of the investigated pediatric glioblastoma cells.